TrialHIV medicine2015

Demographic and HIV-specific characteristics of participants enrolled in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

S Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.